BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19258506)

  • 21. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
    Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
    Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.
    Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y
    Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2 in Bladder Cancer, a Promising Therapeutic Target.
    Martínez-Fernández M; Rubio C; Segovia C; López-Calderón FF; Dueñas M; Paramio JM
    Int J Mol Sci; 2015 Nov; 16(11):27107-32. PubMed ID: 26580594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
    Varambally S; Cao Q; Mani RS; Shankar S; Wang X; Ateeq B; Laxman B; Cao X; Jing X; Ramnarayanan K; Brenner JC; Yu J; Kim JH; Han B; Tan P; Kumar-Sinha C; Lonigro RJ; Palanisamy N; Maher CA; Chinnaiyan AM
    Science; 2008 Dec; 322(5908):1695-9. PubMed ID: 19008416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.
    Koh CM; Iwata T; Zheng Q; Bethel C; Yegnasubramanian S; De Marzo AM
    Oncotarget; 2011 Sep; 2(9):669-83. PubMed ID: 21941025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.
    Banerjee R; Mani RS; Russo N; Scanlon CS; Tsodikov A; Jing X; Cao Q; Palanisamy N; Metwally T; Inglehart RC; Tomlins S; Bradford C; Carey T; Wolf G; Kalyana-Sundaram S; Chinnaiyan AM; Varambally S; D'Silva NJ
    Oncogene; 2011 Oct; 30(42):4339-49. PubMed ID: 21532618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.
    Xie L; Zhang Z; Tan Z; He R; Zeng X; Xie Y; Li S; Tang G; Tang H; He X
    Mol Cell Biochem; 2014 Jul; 392(1-2):153-9. PubMed ID: 24658854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
    Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M
    Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer.
    Friedman JM; Jones PA; Liang G
    Cell Cycle; 2009 Aug; 8(15):2313-4. PubMed ID: 19625769
    [No Abstract]   [Full Text] [Related]  

  • 33. Aberrations of EZH2 in cancer.
    Chase A; Cross NC
    Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
    Zheng F; Liao YJ; Cai MY; Liu YH; Liu TH; Chen SP; Bian XW; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
    Gut; 2012 Feb; 61(2):278-89. PubMed ID: 21672940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.
    Carvalho J; van Grieken NC; Pereira PM; Sousa S; Tijssen M; Buffart TE; Diosdado B; Grabsch H; Santos MA; Meijer G; Seruca R; Carvalho B; Oliveira C
    J Pathol; 2012 Sep; 228(1):31-44. PubMed ID: 22450781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
    Esposito F; Tornincasa M; Pallante P; Federico A; Borbone E; Pierantoni GM; Fusco A
    J Clin Endocrinol Metab; 2012 May; 97(5):E710-8. PubMed ID: 22399519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines.
    Zhang YB; Niu HT; Chang JW; Dong GL; Ma XB
    Eur J Cancer Care (Engl); 2011 Jan; 20(1):106-12. PubMed ID: 20148941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of the Polycomb-Associated Methyltransferase Ezh2 during Maturation of Hippocampal Neurons Is Mediated by MicroRNAs Let-7 and miR-124.
    Guajardo L; Aguilar R; Bustos FJ; Nardocci G; Gutiérrez RA; van Zundert B; Montecino M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.
    Alajez NM; Shi W; Hui AB; Bruce J; Lenarduzzi M; Ito E; Yue S; O'Sullivan B; Liu FF
    Cell Death Dis; 2010 Oct; 1(10):e85. PubMed ID: 21368858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
    Li H; Bitler BG; Vathipadiekal V; Maradeo ME; Slifker M; Creasy CL; Tummino PJ; Cairns P; Birrer MJ; Zhang R
    Cancer Prev Res (Phila); 2012 Mar; 5(3):484-91. PubMed ID: 22144423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.